Page last updated: 2024-10-25

decamethonium and Medulloblastoma

decamethonium has been researched along with Medulloblastoma in 1 studies

decamethonium: RN given refers to parent cpd
decamethonium : A quaternary ammonium ion that is a depolarising muscle relaxant whose structure comprises a decane-1,10-diamine core in which each amino group carries three methyl substituents.

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siegel, HN1
Lukas, RJ1

Other Studies

1 other study available for decamethonium and Medulloblastoma

ArticleYear
Nicotinic agonists regulate alpha-bungarotoxin binding sites of TE671 human medulloblastoma cells.
    Journal of neurochemistry, 1988, Volume: 50, Issue:4

    Topics: Atropine; Bungarotoxins; Carbachol; Cerebellar Neoplasms; Decamethonium Compounds; Humans; Medullobl

1988